Search alternatives:
point decrease » point increase (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), nn decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 wt » _ wt (Expand Search), 5 ht (Expand Search), i wt (Expand Search)
point decrease » point increase (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), nn decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 wt » _ wt (Expand Search), 5 ht (Expand Search), i wt (Expand Search)
-
1981
-
1982
Decreased E/I synapse ratio and loss of cortico-LA synaptic plasticity in the absence of coronin 1.
Published 2014“…(E) Coronin 1–deficient animals (Cor1 −/−, red symbols) exhibited normal thalamo-LA LTP [<i>p</i><0.05 versus baseline; <i>p</i>>0.05 versus wild-type (WT, gray symbols), Student's <i>t</i> test]. Scale bars, 2 mV and 10 ms. …”
-
1983
Annual number of outpatient visits in all eyes.
Published 2025“…In the recurrence group, BCVA (logMAR) showed no significant improvement over time: 0.37 ± 0.20 preoperatively and 0.35 ± 0.23, 0.35 ± 0.18, 0.31 ± 0.23, 0.34 ± 0.26, 0.28 ± 0.30, and 0.24 ± 0.23 at 1, 3, 6, 12, 24, and 36 months, respectively (Kruskal-Wallis test, p = 0.45). In contrast, the non-recurrence group demonstrated significant and sustained improvement from 0.31 ± 0.25 preoperatively to 0.25 ± 0.25, 0.23 ± 0.26, 0.23 ± 0.28, 0.21 ± 0.27, 0.20 ± 0.30, and 0.16 ± 0.30 at corresponding postoperative time points (Kruskal-Wallis test, p < 0.001; <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0332941#pone.0332941.g005" target="_blank">Fig 5</a>).…”
-
1984
-
1985
Rac1 activity rapidly decreases upon cell-cell adhesion in 3-D cell aggregates.
Published 2011“…High levels of active Rac1 at 0 minutes rapidly decreased (∼66%) within 5 minutes of cell-cell adhesion, and declined to a baseline level by 30 minutes (A). …”
-
1986
Neutralization of JRFL WT and mutant viruses by different MAbs and CD4-IgG2.
Published 2018“…B) JRFL WT and mutant neutralization by MAbs targeting V2i, V3, V2q, and the CD4bs and by CD-IgG2. …”
-
1987
-
1988
-
1989
Temperature-Dependent Pyrolysis of Polyamide–Polyethylene Multilayer Films: Yields, Monomer Recovery, and Product Boiling Range
Published 2025“…As expected, increasing the PA-6 share led to a rise in nitrogen (up to 1.5 wt %) and a decrease in hydrogen concentrations in the products in a nonlinear manner. …”
-
1990
Temperature-Dependent Pyrolysis of Polyamide–Polyethylene Multilayer Films: Yields, Monomer Recovery, and Product Boiling Range
Published 2025“…As expected, increasing the PA-6 share led to a rise in nitrogen (up to 1.5 wt %) and a decrease in hydrogen concentrations in the products in a nonlinear manner. …”
-
1991
Temperature-Dependent Pyrolysis of Polyamide–Polyethylene Multilayer Films: Yields, Monomer Recovery, and Product Boiling Range
Published 2025“…As expected, increasing the PA-6 share led to a rise in nitrogen (up to 1.5 wt %) and a decrease in hydrogen concentrations in the products in a nonlinear manner. …”
-
1992
-
1993
-
1994
-
1995
Image_2_EEG 40 Hz Coherence Decreases in REM Sleep and Ketamine Model of Psychosis.TIF
Published 2019“…Because of this fact, REM sleep is considered a natural model of psychosis. Ketamine is a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist that at sub-anesthetic dose induces psychotomimetic-like effects in humans and animals, and is employed as a pharmacological model of psychosis. …”
-
1996
Image_1_EEG 40 Hz Coherence Decreases in REM Sleep and Ketamine Model of Psychosis.TIF
Published 2019“…Because of this fact, REM sleep is considered a natural model of psychosis. Ketamine is a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist that at sub-anesthetic dose induces psychotomimetic-like effects in humans and animals, and is employed as a pharmacological model of psychosis. …”
-
1997
-
1998
-
1999
-
2000